ICM20

IC-MedTech Corporation · Phase 1 active Small molecule

At a glance

Generic name	ICM20
Sponsor	IC-MedTech Corporation
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Phase 1 Study of the Safety and Tolerability of ICM20 in Adults (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

ICM20 CI brief — competitive landscape report
ICM20 updates RSS · CI watch RSS
IC-MedTech Corporation portfolio CI